• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    NovaBay Pharmaceuticals, Inc. (NBY)

    -NYSE MKT
    0.36 Down 0.03(7.38%) Aug 28, 4:00PM EDT
    Add to Portfolio
    Prev Close:0.39
    Open:0.41
    Bid:0.27 x 10000
    Ask:1.15 x 2000
    1y Target Est:1.75
    Beta:-0.869072
    Earnings Date:Nov 10 - Nov 16 (Est.)
    Day's Range:0.36 - 0.42
    52wk Range:0.22 - 1.05
    Volume:192,888
    Avg Vol (3m):318,615
    Market Cap:26.51M
    P/E (ttm):N/A
    EPS (ttm):-0.33
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NBY

    Comparison

    Symbol% ChgMkt Cap
    NBYDown 7.38%26.51M
    SNNUp 1.95%16.16B
    ABTUp 0.83%68.59B
    PFEDown 1.80%201.43B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):13.10
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.28
    Quarterly EPS Est (Sep-15) :-0.07
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes topical non-antibiotic antimicrobial products for the eye care market. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback